V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002397 | 250007147 | 1.72 | 76.3 | Palliative (P) | 2017-08-27 | 2017-09-03 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101234581 |
| 250002399 | 250007149 | null | null | Palliative (P) | null | 2017-01-02 | null | null | N | TRIAL UNSPECIFIED | 100263626 |
| 250002405 | 250007152 | 1.78 | 63.2 | Palliative (P) | 2017-02-28 | 2017-03-11 | CISPLATIN + ETOPOSIDE | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100133184 |
| 250002406 | 250007153 | 1.52 | 106 | Palliative (P) | 2020-05-17 | 2020-05-28 | Cisplatin + Radiotherapy | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101384826 |
| 250002407 | 250007154 | 1.31 | 108.4 | Palliative (P) | 2022-03-13 | 2022-03-13 | Dinutuximab Beta | 02 | N | CISPLATIN + FLUOROURACIL | 100650076 |
| 250002410 | 250007156 | 1.79 | 100.6 | null | 2019-12-10 | 2019-12-24 | GEMCITABINE | 02 | N | TRIAL UNSPECIFIED | 101773111 |
| 250002412 | 250007157 | null | null | null | null | 2018-08-03 | Cisplatin + Radiotherapy | null | null | CAPECITABINE + OXALIPLATIN | 101613599 |
| 250002413 | 250007158 | 1.74 | 69.5 | Curative (C) | null | 2020-10-31 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | SUNITINIB | 100158875 |
| 250002414 | 250007159 | null | null | Palliative (P) | null | 2019-12-14 | null | N | N | NOT MATCHED | 100241738 |
| 250002417 | 250007162 | 1.94 | 61.4 | Palliative (P) | 2016-07-10 | 2016-11-13 | Cisplatin + Pemetrexed | 02 | N | PEMETREXED | 101027279 |
| 250002420 | 250007163 | 1.67 | 108 | null | 2020-02-26 | 2020-03-27 | Carboplatin+Fluorouracil 4 or 5 day | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100019041 |
| 250002429 | 250007165 | 1.6 | 78 | Adjuvant (A) | 2017-09-06 | 2019-11-25 | Trial Unspecified | 02 | N | TIVOZANIB | 100005118 |
| 250002431 | 250007167 | null | null | Palliative (P) | null | 2019-10-18 | Trial Unspecified | null | N | ATEZOLIZUMAB | 100930843 |
| 250002432 | 250007168 | null | null | null | 2021-04-13 | 2021-05-05 | CARBOPLATIN + ETOPOSIDE | 02 | null | ATEZOLIZUMAB | 101247903 |
| 250002437 | 250007171 | 1.62 | 62.2 | null | 2017-05-06 | 2017-05-20 | ICON8B TRIAL | 02 | null | CARBOPLATIN + PEMETREXED | 101580033 |
| 250002439 | 250007172 | 1.62 | 82.65 | null | 2018-03-01 | 2018-03-02 | Trial Unspecified | 02 | N | CISPLATIN + FLUOROURACIL | 101632708 |
| 250002440 | 250007173 | null | null | Palliative (P) | null | 2019-06-28 | null | null | Y | CISPLATIN | 101694139 |
| 250002442 | 250007174 | 1.6 | 126.9 | Palliative (P) | 2017-12-26 | 2018-03-03 | Pazopanib | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100267875 |
| 250002443 | 250007175 | 1.57 | 61.3 | Palliative (P) | 2022-01-11 | 2022-02-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CARBOPLATIN + PEMETREXED | 100227036 |
| 250002445 | 250007176 | 1.55 | 64.8 | Palliative (P) | 2017-08-22 | 2017-09-29 | DOXORUBICIN | 02 | null | CYCLOPHOSPHAMIDE | 101186520 |
| 250002456 | 250007177 | 1.75 | 81.3 | Palliative (P) | null | 2021-07-08 | Temozolomide + RT | 02 | Y | FLUOROURACIL | 100222511 |
| 250002460 | 250007178 | 1.85 | 69.5 | Palliative (P) | null | 2020-02-19 | null | 02 | N | TEMOZOLOMIDE | 100235580 |
| 250002464 | 250007180 | null | null | null | null | 2019-04-22 | CARBOPLATIN + FLUOROURACIL | Y | null | ATEZOLIZUMAB | 100226924 |
| 250002465 | 250007181 | 1 | 0 | null | 2018-06-08 | 2018-06-08 | Carboplatin + Pemetrexed | 01 | null | IPILIMUMAB + NIVOLUMAB | 100402797 |
| 250002475 | 250007186 | null | null | Palliative (P) | 2020-01-17 | 2020-01-17 | null | 02 | null | DOXORUBICIN | 100550452 |
| 250002482 | 250007188 | null | null | null | null | 2018-07-21 | BCG Intravesical | null | null | EVEROLIMUS + LENVATINIB | 101244074 |
| 250002487 | 250007189 | 1.55 | 122.8 | null | 2017-12-28 | 2017-12-29 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100660762 |
| 250002491 | 250007191 | null | null | null | null | 2021-06-05 | null | null | N | TRIAL UNSPECIFIED | 100953347 |
| 250002492 | 250007192 | 1.75 | 88 | Palliative (P) | 2019-11-30 | 2019-12-11 | null | null | null | CARBOPLATIN + CETUXIMAB + FLUOROURACIL | 100743337 |
| 250002493 | 250007193 | 0 | 55.3 | null | 2019-06-14 | 2019-07-02 | FLUOROURACIL + MITOMYCIN + RT | N | null | ATEZOLIZUMAB | 100390503 |
| 250002495 | 250007194 | 1.87 | 88.2 | null | 2020-03-10 | 2020-03-12 | null | 02 | null | CISPLATIN | 101263192 |
| 250002496 | 250007195 | 1.61 | 67.4 | null | 2021-02-08 | 2021-05-14 | BCG Intravesical | 02 | null | IPILIMUMAB + NIVOLUMAB | 101022174 |
| 250002498 | 250007196 | null | null | null | 2021-02-27 | 2021-03-15 | Carboplatin + Pemetrexed | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN | 101816101 |
| 250002501 | 250007198 | 1.63 | 64.4 | null | 2017-01-22 | 2017-03-20 | Cisplatin +Fluorouracil (3 wk) | 02 | N | TRIAL UNSPECIFIED | 101423802 |
| 250002502 | 250007199 | 1.77 | null | null | null | 2020-01-10 | CHOP - 21 days | 02 | null | CAPECITABINE + CARBOPLATIN | 100633098 |
| 250002503 | 250007200 | 1.71 | 61.4 | Curative (C) | null | 2019-02-24 | Erlotinib | 02 | N | CETUXIMAB | 101081853 |
| 250002505 | 250007201 | 1.78 | 82.4 | Palliative (P) | 2019-12-26 | 2019-12-26 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | null | ABIRATERONE | 100572530 |
| 250002506 | 250007202 | 1.62 | 12.2 | null | null | 2018-10-24 | EW EuroEwing 2012 Arm B IE | N | null | PACLITAXEL | 100352838 |
| 250002508 | 250007204 | 1.67 | 73.9 | Palliative (P) | 2018-02-20 | 2018-03-13 | null | 02 | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 101008267 |
| 250002509 | 250007205 | 1.71 | 19.5 | null | 2019-12-15 | 2019-12-24 | Atezolizumab | 02 | N | ATEZOLIZUMAB | 100413560 |
| 250002512 | 250007206 | 1.64 | 84.2 | Palliative (P) | 2018-10-18 | 2018-11-25 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | CAPECITABINE + OXALIPLATIN | 101653937 |
| 250002515 | 250007207 | 1.6 | 87.4 | Curative (C) | 2018-07-26 | 2019-01-07 | EVEROLIMUS | 02 | N | CETUXIMAB | 101254913 |
| 250002518 | 250007209 | 1.21 | 73.5 | null | 2016-10-08 | 2016-10-29 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 100113525 |
| 250002519 | 250007210 | 1.77 | 86 | null | 2020-07-14 | 2020-07-18 | FLUOROURACIL + MITOMYCIN + RT | 02 | null | GEMCARBO | 100586466 |
| 250002531 | 250007214 | null | null | Palliative (P) | 2021-12-25 | 2022-01-01 | TEMOZOLOMIDE | 02 | null | DOCETAXEL + GEMCITABINE | 100477388 |
| 250002534 | 250007216 | 1.77 | 48.8 | Curative (C) | null | 2019-09-20 | Niraparib | 02 | N | ATEZOLIZUMAB | 100519516 |
| 250002541 | 250007218 | 1.54 | 0 | Palliative (P) | 2019-11-09 | 2019-11-22 | null | 01 | null | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 100870402 |
| 250002542 | 250007219 | 1.76 | 76.2 | Palliative (P) | 2019-11-27 | 2019-11-28 | CHOP - 21 days | 02 | null | CETUXIMAB + CISPLATIN + FLUOROURACIL | 100803641 |
| 250000037 | 250007221 | 1.75 | 88 | Palliative (P) | 2017-12-09 | 2018-02-04 | null | 02 | null | NB HRNBL-1 COJEC IND COURSE A | 100063593 |
| 250000084 | 250007222 | 1.73 | 64 | Palliative (P) | 2018-06-27 | 2018-07-03 | EVEROLIMUS + LENVATINIB | 02 | N | FLUOROURACIL + IRINOTECAN | 100334374 |